Home » Tenders » Americas » USA » Japanese Encephalitis Vaccine (JEV) Tender, USA - 105684722

Japanese Encephalitis Vaccine (JEV) Tender, USA - 105684722

DEPT OF DEFENSE | DEFENSE LOGISTICS AGENCY has floated a tender for Japanese Encephalitis Vaccine (JEV). The project location is USA and the tender is closing on 28 Aug 2024. The tender notice number is SPE2DP-24-R-0002, while the TOT Ref Number is 105684722. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Japanese Encephalitis Vaccine (JEV)

Deadline : 28 Aug 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 105684722

Document Ref. No. : SPE2DP-24-R-0002

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Description

Solicitation: SPE2DP-24-R-0002

Item: Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV)

NSN: 6505-01-607-7018

Description:

The Defense Logistics Agency Troop Support has a requirement for the supply of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV). JEV shall be made in accordance with MPID Number 4 dated 30 January 2020, which is attached to this notice.

The Solicitation will be issued under authority 10 U.S.C. 2304(c)(1), only one responsible source.

The Government intends to use Part 12 for this acquisition - per FAR 10.002(d)(2).

The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of a one-year base term. The minimum quantity is 200, 060 EA. The estimated quantity is 208, 320 EA. The maximum quantity is 300, 300 EA.

Inspection/Acceptance at Destination

FOB Destination

Delivery Destination:

DODAAC: SV3100

DLA Distribution Susquehanna

U Avenue, Bldg. 89, Door 6

New Cumberland, PA 17070

Attn: Jim Earp

Production Lead Time is 120 days after issuance date of the delivery order (DD1155).

All responsible sources may submit a proposal and shall be considered by the Agency.

The successful contractor shall have FDA approval to sell JEV before award decision.

****************************************************************************

IMPORTANT NOTICES

Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on h...
Active Contract Opportunity
Notice ID : SPE2DP-24-R-0002
Related Notice : SPE2DP-24-R-0JEV
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEFENSE LOGISTICS AGENCY
Major Command : TROOP SUPPORT MEDICAL
Office: DLA TROOP SUPPORT
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Aug 12, 2024 12:50 pm EDT
Original Response Date: Aug 28, 2024 11:59 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Sep 12, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance: Philadelphia, PA 19111 USA